ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Neurology

Top Neurology Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SHANA KRSTEVSKA M.D.

Neurology

1,929

$349K

244
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$181
Average prescription price

Avg: $293

LORI ANN SCHUH M.D.

Neurology

1,928

$181K

129
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 24%

$94
Average prescription price

Avg: $293

GLEN ACKERMAN M.D.

Neurology

1,927

$954K

231
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$495
Average prescription price

Avg: $293

CHRISTIAN DINSMORE MD

Neurology

1,926

$517K

240
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$268
Average prescription price

Avg: $293

DANIEL HOOD M.D.

Neurology

1,912

$721K

188
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$377
Average prescription price

Avg: $293

PAUL CULLIS MD

Neurology

1,887

$685K

186
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$363
Average prescription price

Avg: $293

ALICIA LUMLEY MD

Neurology

1,885

$427K

159
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$227
Average prescription price

Avg: $293

NEIL GILBERT M.D.

Neurology

1,878

$252K

239
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$134
Average prescription price

Avg: $293

MARIANNA SPANAKI-VARELAS M.D.

Neurology

1,841

$384K

159
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$209
Average prescription price

Avg: $293

TESSY JENKINS M.D.

Neurology

1,838

$841K

180
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

42%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$457
Average prescription price

Avg: $293

STEVEN SHERMAN M.D.

Neurology

1,781

$277K

251
130 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$155
Average prescription price

Avg: $293

ANDREW MARCUS M.D.

Neurology

1,777

$511K

172
80 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$287
Average prescription price

Avg: $293

HEATHER LEE D.O.

Neurology

1,766

$425K

289
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$240
Average prescription price

Avg: $293

SAMI MOUNAYER MD

Neurology

1,759

$816K

315
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$464
Average prescription price

Avg: $293

BORIS LEHETA MD

Neurology

1,755

$453K

225
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$258
Average prescription price

Avg: $293

JEFFREY JONES M.D.

Neurology

1,746

$591K

192
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$338
Average prescription price

Avg: $293

GARY MILLER D.O.

Neurology

1,732

$876K

141
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 24%

$506
Average prescription price

Avg: $293

VAQAR SIDDIQUI MD

Neurology

1,731

$198K

218
59 are 65+

33%
patients receiving schedule two controlled substances

Avg: 3%

48%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$115
Average prescription price

Avg: $293

ROBERT LEVY M.D.

Neurology

1,731

$1.06M

199
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 24%

$615
Average prescription price

Avg: $293

AMY KODRIK D.O.

Neurology

1,712

$345K

176
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$202
Average prescription price

Avg: $293

JULIE BURNHAM D.O.

Neurology

1,682

$934K

203
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 24%

$555
Average prescription price

Avg: $293

MARK KACHADURIAN DO

Neurology

1,672

$779K

204
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 24%

$466
Average prescription price

Avg: $293

RICHARD TROSCH MD

Neurology

1,665

$265K

303
268 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$159
Average prescription price

Avg: $293

ESTHER YOUNG D.O.

Neurology

1,622

$860K

302
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 24%

$530
Average prescription price

Avg: $293

CHAKRAPANI RANGANATHAN MD

Neurology

1,618

$198K

260
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $293

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank